Plasminogen Activators

All categories
DBCAT000074Pharmacologic class

A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. A DrugBank category of 11 drugs. 6 of them are approved.

Also known as
Extrinsic Plasminogen Activators · Plasminogen Activator · Uterine Tissue Plasminogen Activator · Uterine-Tissue Plasminogen Activator
Drugs

What you can answer from here — as of March 01, 2021

11DrugsEach linked to its full drug card
Listed above
29Drug targetsEvery drug–target pair in the class, with bond type
Sign in
120Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
8Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Plasminogen Activators share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In